2021 American Transplant Congress
Assessing the Prevalence of Risk Factors for Osteoporosis and Rate of Screening by Dexa Scan in Patients Referred for Liver Transplant Evaluation
*Purpose: Osteoporosis (OP) and fragility fractures are well-known complications of both chronic liver disease (CLD) and transplant, with a significant increase in the prevalence of…2021 American Transplant Congress
“A New Lease on Life”: Patient Perceptions After Early Liver Transplantation for Alcohol-Related Liver Disease
*Purpose: At some centers, alcohol-related liver disease (ARLD) patients, who are unlikely to survive six months without a liver transplant (LT), are selected to receive…2021 American Transplant Congress
Predictive Factors of the Hepatic Artery Thrombosis in Liver Transplantation Through the Analysis of Donor Characteristics
*Purpose: Hepatic artery thrombosis (HAT) is one of the most severe complications after liver transplantation. It is treated as soon as possible to avoid irreversible…2021 American Transplant Congress
Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis
*Purpose: This study aims to evaluate regional trends in liver transplantation (LT) among adults in the United States (US) with nonalcoholic steatohepatitis (NASH), with particular…2021 American Transplant Congress
Update on Domino Liver Transplants – A Registry Report
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: The ongoing shortage of livers in the setting of a growing waiting list remains a challenge in transplantation. First introduced in 1996, domino liver…2021 American Transplant Congress
Early Effects of Acuity Circle-Based Liver Allocation During Covid-19 Pandemic in the United States
Henry Ford Hospital, Detroit, MI
*Purpose: One month before the COVID-19 pandemic was declared, liver transplant (LT) allocation in the US was updated (February 4th, 2020), by introducing the acuity…2021 American Transplant Congress
Application of Linear Discriminant Analysis (lda) to Differentiate Acute Rejection (ar) and Acute Dysfunction Non-Rejection (adnr) in Liver Transplant Recipients
*Purpose: Blood-based biomarkers distinguishing acute-rejection (AR) from other causes of graft dysfunction (acute dysfunction non-rejection (ADNR)) would have significant clinical applicability in liver transplant (LT)…2021 American Transplant Congress
Re-Do Hepatic Artery Reconstruction for Thrombosis Can Save Grafts and Patients without Retransplantation: Lessons Learned from 1,355Adult Living Donor Liver Transplantations
Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: Hepatic artery thrombosis (HAT) after liver transplantation is associated with a marked increase in morbidity, being the main cause of graft loss and bile…2021 American Transplant Congress
Impact of Transplant Center Volume on Utilization of and Outcomes Following Donation After Circulatory Death Liver Transplantation in the United States
*Purpose: Despite increased utilization of donation after circulatory death (DCD) grafts in the US, impact of center volume on DCD liver transplantation (LT) remains unclear.…2021 American Transplant Congress
Relationship of Functional Frailty and Radiographic Sarcopenia to Outcomes After Liver Transplant
Comprehensive Transplant Center, Northwestern University, Chicago, IL
*Purpose: Frailty and sarcopenia are associated with increased risk of hospitalization and mortality in end stage liver disease patients. Frailty can be measured clinically using…
- « Previous Page
- 1
- …
- 28
- 29
- 30
- 31
- 32
- …
- 180
- Next Page »